Cranial nerve and cervical root enhancement in an infant with polymerase gamma mutation mitochondrial disease

Deanna M Horst1, Lynne Ruess2, Jerome A Rusin2

  • 1Department of Radiology, Nationwide Children's Hospital, Columbus, Ohio.

Pediatric Neurology
|October 8, 2014
PubMed

Insights

Mutations in nuclear polymerase gamma (POLG) cause inherited mitochondrial disease. This case highlights abnormal cranial nerve enhancement on MRI in an infant with POLG-related myocerebrohepatopathy spectrum disease.

Area of Science:

  • Neurology
  • Genetics
  • Pediatrics

Background:

  • Nuclear polymerase gamma (POLG) mutations are a leading cause of inherited mitochondrial disease.
  • POLG-related disorders present with diverse clinical symptoms, including the severe infantile myocerebrohepatopathy spectrum.

Observation:

  • A 4-month-old infant presented with poor feeding, vomiting, failure to thrive, and hypotonia.
  • Brain MRI revealed bilateral enhancement of cranial nerves III, V-X, and upper/midcervical nerve roots, alongside mild cerebral atrophy.
  • Liver biopsy showed early cirrhosis, steatosis, and necrosis; muscle biopsy was unremarkable for morphology.

Findings:

  • Electron transport chain analysis in fibroblasts and muscle indicated deficiencies.
  • Genetic testing identified two pathogenic POLG mutations: c.1399G>A (p.A467T) and c.3285C>G (p.S1095R).
  • This confirmed a diagnosis of mitochondrial depletion disorder due to POLG mutations.

Implications:

  • Abnormal gadolinium enhancement of multiple cranial nerves and cervical nerve roots can be a sign of POLG-related mitochondrial disease.
  • Mitochondrial disease should be considered in the differential diagnosis for infants exhibiting cranial nerve enhancement on MRI.
  • Contrast-enhanced MRI is a valuable tool for diagnosing suspected neurological conditions in infants with developmental delay.
Abstract